• Home
  • Day: January 11, 2023

Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD)

Global Phase 3 INDIGO study will evaluate the efficacy and safety of obexelimab in patients with IgG4-RD, a chronic and serious fibroinflammatory disease typically affecting multiple organs IgG4-RD is the first of several potential disease indications to be pursued for obexelimab given its unique non-depleting, B-cell inhibition WALTHAM, Mass., Jan.…

Journalists called to enter 2023 SADC Media Awards

South African media have been invited to submit their entries for the 2023 SADC Media Awards competition.In a statement on Wednesday, the Government Communication and Information System (GCIS) said the SADC Media Awards are open to journalists from the Southern African Development Community (SADC) member states. “The first prize winners…

MEC Mireille Wenger on Cape Town International Airport passenger statistics

Spectacular recovery in passenger numbers at Cape International Airport over December 2022Provincial Minister of Finance and Economic Opportunities, Mireille Wenger today warmly welcomed preliminary statistics received from Airports Company South Africa (ACSA), which showed that Cape Town International Airport recorded a spectacular recovery in passenger numbers during the peak season…